Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor.
Vanderbilt University has signed a licensing agreement with Nashville-based start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) for the treatment of Parkinson’s disease.
High-density lipoprotein (HDL) is widely thought to protect against the development of atherosclerosis, yet drugs that raise levels of HDL cholesterol (HDL-C) have failed to reduce the risk of heart disease.
Todd Giorgio, professor of biomedical engineering, has been selected by the Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) to attend a Mobile Health Training Institute at UCLA July 29-Aug. 3.
For years, he’s been visiting a Vanderbilt University mechanical engineering laboratory, making a difference by testing a new “smart” prosthetic ankle that moves with the user.
The Top 100 Worldwide Universities Granted U.S. Utility Patents in 2017 has been announced by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO). Data obtained from the U.S. Patent and Trademark Office (USPTO) is used to compile the report, which highlights the vital role patents play in university research and innovation.
